These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 4145870)

  • 41. Neuronally mediated enzyme induction in adrenergic neurons and adrenal chromaffin cells.
    Thoenen H
    Biochem Soc Symp; 1972; (36):3-15. PubMed ID: 4155629
    [No Abstract]   [Full Text] [Related]  

  • 42. 6-Hydroxydopamine induced catecholamine depletion and passive avoidance learning in rats.
    Oei TP; Ng CP
    Pharmacol Biochem Behav; 1978 May; 8(5):553-6. PubMed ID: 674261
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Adaptation to the behavioral effects of 6-hydroxydopamine].
    Semenova TP; Tret'iak TM; Grishchenko NI; Smirnova GN
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1983; 33(1):163-5. PubMed ID: 6404069
    [No Abstract]   [Full Text] [Related]  

  • 44. Ingestive behavior following damage to central dopamine neurons: implications for homeostasis and recovery of function.
    Zigmond MJ; Stricker EM
    Adv Biochem Psychopharmacol; 1974; 12(0):385-402. PubMed ID: 4609140
    [No Abstract]   [Full Text] [Related]  

  • 45. Proceedings: Impaired response control in the rat after 6-hydroxydopamine lesions to the dorsal noradrenaline bundles.
    Iversen SD; Mason ST
    Br J Pharmacol; 1975 Oct; 55(2):293P. PubMed ID: 1201421
    [No Abstract]   [Full Text] [Related]  

  • 46. Long-term effects of postnatal 6-hydroxydopamine treatment on tissue catecholamine levels.
    Lytle LD; Shoemaker WJ; Cottman K; Wurtman RJ
    J Pharmacol Exp Ther; 1972 Oct; 183(1):56-64. PubMed ID: 5080034
    [No Abstract]   [Full Text] [Related]  

  • 47. Behavioral and biochemical effects of the antidepressant bupropion (Wellbutrin): evidence for selective blockade of dopamine uptake in vivo.
    Cooper BR; Hester TJ; Maxwell RA
    J Pharmacol Exp Ther; 1980 Oct; 215(1):127-34. PubMed ID: 6778989
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of 4-chlorophenoxyamphetamine (A-6587), d-amphetamine and 4-chloroamphetamine on brain biogenic amines and behavior in mice.
    Everett GM; Yellin TO
    Res Commun Chem Pathol Pharmacol; 1971; 2(4):407-13. PubMed ID: 4400361
    [No Abstract]   [Full Text] [Related]  

  • 49. Narcotic antagonists as stimulants of behavior in the rat: specific and nonspecific effects.
    Holtzman SG
    Adv Biochem Psychopharmacol; 1973; 8(0):371-82. PubMed ID: 4794990
    [No Abstract]   [Full Text] [Related]  

  • 50. Some actions of pentazocine on behavior and brain monoamines in the rat.
    Holtzman SG; Jewett RE
    J Pharmacol Exp Ther; 1972 May; 181(2):346-56. PubMed ID: 5030675
    [No Abstract]   [Full Text] [Related]  

  • 51. Norepinephrine and dopamine in the developing chick brain.
    Kobayashi K; Eiduson S
    Dev Psychobiol; 1970; 3(1):13-34. PubMed ID: 4146802
    [No Abstract]   [Full Text] [Related]  

  • 52. Effects on homeostasis of intraventricular injections of 6-hydroxydopamine in rats.
    Stricker EM; Zigmond MJ
    J Comp Physiol Psychol; 1974 Jun; 86(6):973-94. PubMed ID: 4836848
    [No Abstract]   [Full Text] [Related]  

  • 53. Depletion of brain noradrenaline, but not dopamine, by intracerebral 6-hydroxydopamine potentiates convulsions induced by electroshock.
    Mason ST; Corcoran ME
    J Pharm Pharmacol; 1979 Apr; 31(4):209-11. PubMed ID: 36457
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dopamine depletion by 6-hydroxydopamine prevents conditioned taste aversion induced by methylamphetamine but not lithium chloride.
    Wagner GC; Foltin RW; Seiden LS; Schuster CR
    Pharmacol Biochem Behav; 1981 Jan; 14(1):85-8. PubMed ID: 7465611
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Possible behavioural function for noradrenaline--acetylcholine interaction in brain.
    Mason ST; Fibiger HC
    Nature; 1979 Feb; 277(5695):396-6. PubMed ID: 575915
    [No Abstract]   [Full Text] [Related]  

  • 56. Effects of neonatal 6-hydroxydopamine treatment on catecholamine levels and behavior during development and adulthood.
    Fobes JL; Olds ME
    Psychopharmacology (Berl); 1981; 73(1):27-30. PubMed ID: 6785785
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Diencephalic dopamine cell groups: correlations with endocrine status.
    Shoemaker WJ; Schlumpf M
    Adv Biochem Psychopharmacol; 1977; 16():359-67. PubMed ID: 18887
    [No Abstract]   [Full Text] [Related]  

  • 58. Long-term deficits in stimulation-induced behaviors and self-stimulation after 6-hydroxydopamine administration in rats.
    Phillips AG; Fibiger HC
    Behav Biol; 1976 Feb; 16(2):127-43. PubMed ID: 1259675
    [No Abstract]   [Full Text] [Related]  

  • 59. Behavioral effects of profadol in the rat.
    Holtzman SG
    Psychopharmacologia; 1974 Jan; 34(2):135-42. PubMed ID: 4818022
    [No Abstract]   [Full Text] [Related]  

  • 60. Effect of intraventricular injections of 6-hydroxydopamine in neonatal rats on the catecholamine levels and tyrosine hydroxylase activity in brain regions at maturity.
    Peters DA; Pappas BA; Taub H; Saari M
    Biochem Pharmacol; 1977 Dec; 26(23):2211-5. PubMed ID: 22332
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.